~~<i id='956CF1AFE6'><strike id='956CF1AFE6'><tt id='956CF1AFE6'><pre id='956CF1AFE6'></pre></tt></strike></i>~~

Home» explore» entertainment

entertainment

author：comprehensive 2025-08-08 04:16:37 Page View：23

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Making the case for fair compensation in clinical trials
Next article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

FDA poised to publish guidelines for clinical trial diversity

AdobeTheFoodandDrugAdministrationispoisedtotelldrugandmedicaldevicemakershowtobetterincludepeopleofc

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

'Patient friction coefficient' can gauge a clinical trial's patient burden

AdobeTherigorandcomplexityneededtogeneratemeasurableresultsfromclinicaltrialsoftenmakesthemdifficult